文献速递产科母胎医学

产前抑郁中的胎盘加速老化

Placental accelerated aging in antenatal depression.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-11-25

本研究纳入301名在美国12个临床中心招募、2009—2013年分娩时提供胎盘样本的孕妇,用爱丁堡产后抑郁量表在三个孕期最多筛查6次,评估产前抑郁症状与胎盘表观遗传年龄加速的关系。结果显示,孕中期有抑郁症状者胎盘年龄加速平均高0.41周,孕早期和孕中期持续有抑郁症状者高0.72周,提示胎盘加速老化可能部分介导产前抑郁与胎盘功能障碍相关妊娠并发症的关联。

要点

  • 孕中期爱丁堡产后抑郁量表评分≥10分者,胎盘年龄加速较无抑郁症状者平均高0.41周(95%CI 0.10–0.71,P=.009)。
  • 孕早期和孕中期持续有抑郁症状者,胎盘年龄加速较两孕期均无抑郁症状者高0.72周(95%CI 0.29–1.15,P=.001)。
  • 孕早期和孕晚期抑郁症状与胎盘年龄加速的关联未达统计学显著。

核心结论

  • 孕中期产前抑郁症状与胎盘年龄加速平均增加0.41周相关;胎盘加速老化可能在产前抑郁与胎盘功能障碍相关妊娠并发症的关联机制中起重要作用。

研究设计与样本

  • 研究纳入301名在2009—2013年于美国12个临床中心招募、分娩时提供胎盘样本的孕妇,数据来自尤妮斯·肯尼迪·施莱佛国家儿童健康与人类发展研究所胎儿生长研究—单胎。
  • 孕期用爱丁堡产后抑郁量表在三个孕期最多筛查6次,评分≥10分定义为有抑郁症状,<10分为无抑郁症状。
  • 胎盘DNA甲基化用于估算胎盘表观遗传年龄,胎盘年龄加速定义为估算表观遗传年龄对分娩时孕龄回归的残差。
  • 用多变量线性回归分析各孕期抑郁症状与胎盘年龄加速的关联,校正母亲年龄、产次、种族和民族及就业情况。

主要发现

  • 孕早期、孕中期、孕晚期分别有31名(10.3%)、48名(16%)、49名(16.4%)孕妇有抑郁症状(爱丁堡产后抑郁量表评分≥10分)。
  • 孕早期和孕中期持续有抑郁症状者21名(7.2%),孕中期和孕晚期持续有抑郁症状者19名(7%),整个孕期持续有抑郁症状者12名(4.8%)。
  • 孕中期有抑郁症状者胎盘年龄加速较孕中期无抑郁症状者高0.41周(β=0.41周,95%CI 0.10–0.71,P=.009);孕早期β=0.21周(95%CI -0.17–0.58,P=.28),孕晚期β=0.17周(95%CI -0.14–0.47,P=.29),均未达统计学显著。
  • 孕早期和孕中期持续有抑郁症状者胎盘年龄加速较两孕期均无抑郁症状者高0.72周(95%CI 0.29–1.15,P=.001)。
  • 在男胎妊娠分析中,孕中期抑郁症状与胎盘表观遗传年龄加速的关联增强(β=0.53周,95%CI 0.06–1.08,P=.03),女胎妊娠中不显著。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antenatal maternal depression is associated with poor pregnancy outcomes and long-term effects on the offspring. Previous studies have identified links between antenatal depression and placental DNA methylation and between placental epigenetic aging and poor pregnancy outcomes, such as preterm labor and preeclampsia. The relationship between antenatal depression and poor pregnancy outcomes may be partly mediated via placental aging. OBJECTIVE: This study aimed to investigate whether antenatal depressive symptoms are associated with placental epigenetic age acceleration, an epigenetic aging clock measure derived from the difference between methylation age and gestational age at delivery. STUDY DESIGN: The study included 301 women who provided placenta samples at delivery as part of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies - Singletons that recruited participants from diverse race and ethnic groups at 12 US clinical sites (2009-2013). Women underwent depression screening using the Edinburgh Postnatal Depression Scale up to 6 times across the 3 trimesters of pregnancy. Depressive symptoms status was determined for each pregnancy trimester using an Edinburgh Postnatal Depression Scale score, in which a score of ≥10 was defined as having depressive symptoms and a score of <10 was defined as not having depressive symptoms. Placental DNA methylation was profiled from placenta samples. Placental epigenetic age was estimated using a methylation-based age estimator (placental "epigenetic clock") that has previously been found to have high placental gestational age prediction accuracy for uncomplicated term pregnancies. Placental age acceleration was defined to be the residual upon regressing the estimated epigenetic age on gestational age at delivery. Associations between an Edinburgh Postnatal Depression Scale score of ≥10 and an Edinburgh Postnatal Depression Scale score of <10 in the first, second, and third trimesters of pregnancy (ie, depressive symptoms vs none in each trimester) and placental age acceleration were tested using multivariable linear regression adjusting for maternal age, parity, race and ethnicity, and employment. RESULTS: There were 31 (10.3%), 48 (16%), and 49 (16.4%) women with depressive symptoms (ie, Edinburgh Postnatal Depression Scale score of ≥10) in the first, second, and third trimesters of pregnancy, respectively. Of these women, 21 (7.2%) had sustained first- and second-trimester depressive symptoms, 19 (7%) had sustained second- and third-trimester depressive symptoms, and 12 (4.8%) had sustained depressive symptoms throughout pregnancy. Women with depressive symptoms in the second trimester of pregnancy had 0.41 weeks higher placental age acceleration than women without depressive symptoms during the second trimester of pregnancy (β=0.21 weeks [95% confidence interval, -0.17 to 0.58; P=.28] during the first trimester of pregnancy; β=0.41 weeks [95% confidence interval, 0.10-0.71; P=.009] during the second trimester of pregnancy; β=0.17 weeks [95% confidence interval, -0.14 to 0.47; P=.29] during the third trimester of pregnancy). Sustained first- and second-trimester depressive symptoms were associated with 0.72 weeks higher placental age acceleration (95% confidence interval, 0.29-1.15; P=.001) than no depressive symptom in the 2 trimesters. The association between second-trimester depressive symptoms and higher placental epigenetic age acceleration strengthened in the analysis of pregnancies with male fetuses (β=0.53 weeks; 95% confidence interval, 0.06-1.08; P=.03) but was not significant in pregnancies with female fetuses. CONCLUSION: Antenatal depressive symptoms during the second trimester of pregnancy were associated with an average of 0.41 weeks of increased placental age acceleration. Accelerated placental aging may play an important role in the underlying mechanism linking antenatal depression to pregnancy complications related to placental dysfunction.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Saeed H, Wu J, Tesfaye M, et al. Placental accelerated aging in antenatal depression. Am J Obstet Gynecol MFM. 2023. PMID: 38012987. doi:10.1016/j.ajogmf.2023.101237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。